These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25445944)

  • 1. Physicians' and patients' expectations of therapies for pulmonary arterial hypertension: where do they meet?
    Howard LS; Ferrari P; Mehta S
    Eur Respir Rev; 2014 Dec; 23(134):458-68. PubMed ID: 25445944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives.
    Guillevin L; Armstrong I; Aldrighetti R; Howard LS; Ryftenius H; Fischer A; Lombardi S; Studer S; Ferrari P
    Eur Respir Rev; 2013 Dec; 22(130):535-42. PubMed ID: 24293469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension: the burden of disease and impact on quality of life.
    Delcroix M; Howard L
    Eur Respir Rev; 2015 Dec; 24(138):621-9. PubMed ID: 26621976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients', relatives', and practitioners' views of pulmonary arterial hypertension: A qualitative study.
    Alami S; Cottin V; Mouthon L; Desjeux D; Quessette E; Poiraudeau S; Sitbon O
    Presse Med; 2016 Feb; 45(2):e11-27. PubMed ID: 26775203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
    Studer SM; Gilkin RJ
    Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges in paediatric pulmonary arterial hypertension.
    Beghetti M; Berger RM
    Eur Respir Rev; 2014 Dec; 23(134):498-504. PubMed ID: 25445948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension.
    Hill NS; Cawley MJ; Heggen-Peay CL
    J Manag Care Spec Pharm; 2016 Mar; 22(3 Suppl A):S3-21. PubMed ID: 27003666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to detect disease progression in pulmonary arterial hypertension.
    Vachiéry JL; Yerly P; Huez S
    Eur Respir Rev; 2012 Mar; 21(123):40-7. PubMed ID: 22379173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical analysis of survival in pulmonary arterial hypertension.
    O'Callaghan DS; Humbert M
    Eur Respir Rev; 2012 Sep; 21(125):218-22. PubMed ID: 22941886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.
    Condliffe R; Kiely DG; Peacock AJ; Corris PA; Gibbs JS; Vrapi F; Das C; Elliot CA; Johnson M; DeSoyza J; Torpy C; Goldsmith K; Hodgkins D; Hughes RJ; Pepke-Zaba J; Coghlan JG
    Am J Respir Crit Care Med; 2009 Jan; 179(2):151-7. PubMed ID: 18931333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension.
    Preston IR; Suissa S; Humbert M
    Eur Respir Rev; 2013 Dec; 22(130):495-502. PubMed ID: 24293465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension.
    Gaine S; Simonneau G
    Eur Respir Rev; 2013 Dec; 22(130):487-94. PubMed ID: 24293464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Shapiro S; Traiger GL; Turner M; McGoon MD; Wason P; Barst RJ
    Chest; 2012 Feb; 141(2):363-373. PubMed ID: 21757572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease.
    Howard LS
    Eur Respir Rev; 2011 Dec; 20(122):236-42. PubMed ID: 22130816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.
    Price LC; Dimopoulos K; Marino P; Alonso-Gonzalez R; McCabe C; Kemnpy A; Swan L; Boutsikou M; Al Zahrani A; Coghlan GJ; Schreiber BE; Howard LS; Davies R; Toshner M; Pepke-Zaba J; Church AC; Peacock A; Corris PA; Lordan JL; Gaine S; Condliffe R; Kiely DG; Wort SJ
    Thorax; 2017 Nov; 72(11):1035-1045. PubMed ID: 28904006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
    Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD
    Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of severe pulmonary arterial hypertension.
    Vachiéry JL; Simonneau G
    Eur Respir Rev; 2010 Dec; 19(118):279-87. PubMed ID: 21119186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
    Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
    Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial hypertension--contemporary management strategy.
    Jansa P; Ambroz D; Maresova J; Polacek P; Aschermann M; Linhart A
    Bratisl Lek Listy; 2009; 110(10):603-8. PubMed ID: 20017449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.